GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 25.88% to -21 cents per share on May 14
Q1'25
Est.
$-0.21
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.08
The last earnings report on February 27 showed earnings per share of -17 cents, beating the estimate of -22 cents. With 610.69K shares outstanding, the current market capitalization sits at 568.18M.